Outcomes associated with trimethoprim/sulphamethoxazole (TMP/SMX) therapy in TMP/SMX resistant community-acquired UTI. (Q34756637)

4 August 2017

1 reference

title

Outcomes associated with trimethoprim/sulphamethoxazole (TMP/SMX) therapy in TMP/SMX resistant community-acquired UTI. (English)

1 reference

4 August 2017

Kalpana Gupta

1

1 reference

4 August 2017

Walter E Stamm

series ordinal

2

1 reference

4 August 2017

publication date

1 June 2002

1 reference

International Journal of Antimicrobial Agents

4 August 2017

published in

1 reference

4 August 2017

volume

19

1 reference

4 August 2017

issue

6

1 reference

4 August 2017

page(s)

554-556

1 reference

Increasing prevalence of antimicrobial resistance among uropathogens causing acute uncomplicated cystitis in women

4 August 2017

cites work

1 reference

https://api.crossref.org/works/10.1016%2FS0924-8579%2802%2900104-8

7 January 2021

Antimicrobial resistance among uropathogens that cause community-acquired urinary tract infections in women: a nationwide analysis

1 reference

https://api.crossref.org/works/10.1016%2FS0924-8579%2802%2900104-8

7 January 2021

Prevalence of antimicrobial resistance among urinary tract pathogens isolated from female outpatients across the US in 1999.

1 reference

https://api.crossref.org/works/10.1016%2FS0924-8579%2802%2900104-8

7 January 2021

Multidrug-resistant urinary tract isolates of Escherichia coli: prevalence and patient demographics in the United States in 2000.

1 reference

https://api.crossref.org/works/10.1016%2FS0924-8579%2802%2900104-8

7 January 2021

Guidelines for antimicrobial treatment of uncomplicated acute bacterial cystitis and acute pyelonephritis in women. Infectious Diseases Society of America (IDSA).

1 reference

https://api.crossref.org/works/10.1016%2FS0924-8579%2802%2900104-8

7 January 2021

Diagnosis and treatment of uncomplicated urinary tract infection

1 reference

https://api.crossref.org/works/10.1016%2FS0924-8579%2802%2900104-8

7 January 2021

High-dosage co-amoxiclav in a single dose versus 7 days of co-trimoxazole as treatment of uncomplicated lower urinary tract infection in women

1 reference

https://api.crossref.org/works/10.1016%2FS0924-8579%2802%2900104-8

7 January 2021

A randomized trial of short-course ciprofloxacin, ofloxacin, or trimethoprim/sulfamethoxazole for the treatment of acute urinary tract infection in women. Ciprofloxacin Urinary Tract Infection Group

1 reference

https://api.crossref.org/works/10.1016%2FS0924-8579%2802%2900104-8

7 January 2021

Increasing antimicrobial resistance and the management of uncomplicated community-acquired urinary tract infections

1 reference

https://api.crossref.org/works/10.1016%2FS0924-8579%2802%2900104-8

7 January 2021

Empirical therapy for uncomplicated urinary tract infections in an era of increasing antimicrobial resistance: a decision and cost analysis

1 reference

https://api.crossref.org/works/10.1016%2FS0924-8579%2802%2900104-8

7 January 2021

Empiric use of trimethoprim-sulfamethoxazole (TMP-SMX) in the treatment of women with uncomplicated urinary tract infections, in a geographical area with a high prevalence of TMP-SMX-resistant uropathogens.

1 reference

https://api.crossref.org/works/10.1016%2FS0924-8579%2802%2900104-8

7 January 2021

Comparison of ciprofloxacin (7 days) and trimethoprim-sulfamethoxazole (14 days) for acute uncomplicated pyelonephritis pyelonephritis in women: a randomized trial

1 reference

https://api.crossref.org/works/10.1016%2FS0924-8579%2802%2900104-8

7 January 2021

10.1016/S0924-8579(02)00104-8

Identifiers

DOI

1 reference

4 August 2017

1 reference